康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01681 康臣药业

未开盘 05-04 16:08:22

16.140

-0.080

-0.49%

最高16.310	最低15.900	成交量60.21万
今开16.230	昨收16.220	日振幅2.53%
总市值135.90亿	流通市值135.90亿	总股本8.42亿
成交额973.01万	换手率0.07%	流通股本8.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":16.14,"timestamp":1777882102003,"preClose":16.22,"halted":0,"volume":602067,"delay":0,"changeRate":-0.004932182490752053,"floatShares":842000000,"shares":842000000,"eps":1.4443274111675128,"marketStatus":"未开盘","change":-0.08,"latestTime":"05-04 16:08:22","open":16.23,"high":16.31,"low":15.9,"amount":9730061,"amplitude":0.025277,"askPrice":16.14,"askSize":3000,"bidPrice":16.09,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":1.4443274111675128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777944600000},"marketStatusCode":0,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":16.22,"dividendRate":0.046262,"openAndCloseTimeList":[[1777858200000,1777867200000],[1777870800000,1777881600000]],"volumeRatio":0.589892,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681","defaultTab":"news","newsList":[{"id":"1105671593","title":"康臣药业更新2026年4月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1105671593","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105671593?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:50","pubTimestamp":1777884655,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年5月4日披露了截至2026年4月30日的证券变动月报表，显示报告期内公司股本结构保持稳定，已发行股本和注册股本均未发生增减变化。在股份期权及激励计划方面，公告指出，截至4月末，2013年12月采纳的购股权计划下余额由7,074,153份减少为0，该变动并未引发任何新股发行或相关股份转让。2024年5月采纳的另一项购股权计划虽然本月并无新增期权，但公告披露其尚有84,281,191股潜在可行使期权额度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632046326","title":"打造“肾科旗舰”领先竞争优势，康臣药业(01681)估值重构进行时","url":"https://stock-news.laohu8.com/highlight/detail?id=2632046326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632046326?lang=zh_cn&edition=full","pubTime":"2026-05-03 17:30","pubTimestamp":1777800600,"startTime":"0","endTime":"0","summary":"4月21日，康臣药业于深圳举办港股通标的庆典暨投资者交流会，在这次活动中，董事局主席、总裁安猛以及多位核心高管分享了公司业务表现和战略规划，并就公司未来增长潜力与投资者进行了深入的探讨。3月9日，根据港股通标的调整通告，42家企业被新调入港股通名单，康臣药业便是其中之一。可见，当前资本市场对康臣药业的定价依然存在显著的认知差与估值错位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177213883","title":"康臣药业(01681)2025年报：收入同比增15.2%至34.17亿元 股东应占溢利增长18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177213883","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177213883?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:25","pubTimestamp":1777368342,"startTime":"0","endTime":"0","summary":"康臣药业在2025年度整体经营稳健上行，收入同比增长15.2%至约人民币34.17亿元，股东应占溢利约人民币10.78亿元，同比上升18.4%，总资产规模较上年末增长至人民币64.10亿元，反映综合实力和盈利能力进一步提升。对比剂业务收入约人民币1.88亿元，同比增长10.9%，新老产品在多省集采及学术推广项目中均取得进展。妇儿药板块实现销售约人民币3.76亿元，同比增长4.0%，以病例库编纂和学术活动为抓手，进一步提升了在围产及妇儿领域的市场影响力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)2025年报：收入同比增15.2%至34.17亿元 股东应占溢利增长18.4%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157294532","title":"康臣药业将于2026年5月26日派发末期股息每股0.40港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157294532","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157294532?lang=zh_cn&edition=full","pubTime":"2026-04-28 06:41","pubTimestamp":1777329719,"startTime":"0","endTime":"0","summary":"康臣药业(01681)于最新公告中披露，公司董事会已建议就截至2025年12月31日止年度派发末期股息每股0.40港元，相关方案将于2026年5月26日举行的股东周年大会上审议。根据公告，股东如欲符合领取该末期股息的资格，须于2026年6月10日下午4时30分前完成股份过户登记手续。董事会并表示，股东可选择亲身及/或通过在线平台参与相关会议并投票。本次股息分派仍有待股东正式批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业将于2026年5月26日派发末期股息每股0.40港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101317039","title":"康臣药业授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1101317039","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101317039?lang=zh_cn&edition=full","pubTime":"2026-04-28 06:41","pubTimestamp":1777329687,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司在最新公告中提出一项股份购回计划，将于股东周年大会上提请授予董事在会议通过之日其已发行股本最多10%的购回授权。该公司于公告中披露，截至最后可行日期，公司已发行总股份约为8.415亿股，若本次授权获准并全数行使，最高可购回约8415万股。另据公告，康臣药业股份于香港联合交易所主板上市。董事会强调，若行使购回授权，将根据适用法规合规操作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830658","title":"康臣药业（01681.HK）投资者交流日：稳增长、高分红双轮驱动获青睐","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830658","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629830658?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:53","pubTimestamp":1776952393,"startTime":"0","endTime":"0","summary":"康臣药业正以稳健的基本盘、持续提升的股东回报和清晰可见的成长路径，为价值投资写下生动注脚。","market":"sh","thumbnail":"https://img2.gelonghui.com/aaa26-e5e9f8f2-b739-4c80-9dfe-a4343d62cc06.jpg?guru_height=2160&guru_width=3840&guru_size=1818159","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/aaa26-e5e9f8f2-b739-4c80-9dfe-a4343d62cc06.jpg?guru_height=2160&guru_width=3840&guru_size=1818159"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4527988","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4585","VIG","BK1191","BK1606","01681","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629104016","title":"【券商聚焦】兴业证券：康臣药业(01681)2025年业绩延续高质量增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629104016","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629104016?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:58","pubTimestamp":1776848338,"startTime":"0","endTime":"0","summary":"金吾财讯 | 兴业证券发布研报指，康臣药业 2025年业绩延续高质量增长态势，营收与利润双双实现双位数增长，核心肾科业务增速领跑，创新研发实现全球化突破，高派息与股份回购彰显管理层信心。公司2025年实现营业收入34.17亿元，同比增长15.2%；归母净利润10.78亿元，同比增长18.4%；毛利率同比提升2.4个百分点至78.0%。肾科药物实现销售收入24.02亿元，同比增长20.3%，增速领跑全板块。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979649","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0188","BK0276","01681","BK0028","BK0183","601377","BK1606","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625937622","title":"稳健基本面叠加入通利好，康臣药业(01681)迎关键配置窗口期","url":"https://stock-news.laohu8.com/highlight/detail?id=2625937622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625937622?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:31","pubTimestamp":1775561483,"startTime":"0","endTime":"0","summary":"内地资金对医药、中成药、独家品种中成药的理解和偏好，对于顺利入通且一直保持稳健基本面的康臣药业而言，无疑是极大利好。稳健基本面叠加稳定高派息得益于核心品种尿毒清颗粒的助推以及多专科持续发力，2025年康臣药业继续保持稳中有升的基本面，同时延续高额派息。数据显示，截至目前的近一年内，康臣药业已累计回购59次，回购股数达1368.0万股，累计金额达到1.85亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624998666","title":"一图看懂康臣药业(01681.HK)2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2624998666","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624998666?lang=zh_cn&edition=full","pubTime":"2026-04-04 13:30","pubTimestamp":1775280645,"startTime":"0","endTime":"0","summary":"一图看懂康臣药业(01681.HK)2025年度业绩","market":"fut","thumbnail":"https://img2.gelonghui.com/f0fea-9a6bdd08-8bab-4d08-8a5e-00de492003c1.png?guru_height=375&guru_width=540&guru_size=415615","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/f0fea-9a6bdd08-8bab-4d08-8a5e-00de492003c1.png?guru_height=375&guru_width=540&guru_size=415615"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4307919","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109004489","title":"康臣药业更新3月股份变动月报表，已发行股数略有上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1109004489","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109004489?lang=zh_cn&edition=full","pubTime":"2026-04-02 12:11","pubTimestamp":1775103104,"startTime":"0","endTime":"0","summary":"康臣药业4月2日发布2026年3月股份变动月报表。报告期截至2026年3月31日，公司法定股本数量维持在5,000,000,000股，面值每股0.1港元，注册股本总额500,000,000港元，与上月底持平。报告期内，公司已发行股份数由上月底的841,423,111股上调至841,547,111股，增幅为124,000股。本次增发源于购股期权的行使，涉及于2013年12月2日采纳的购股权计划。公司声明已遵守香港联交所《上市规则》及相关法律规定。本次月报由公司秘书高海恩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185427759","title":"异动解读 | 康臣药业盘中大涨5.15%，2025年业绩亮眼溢利同比增长18.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185427759","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185427759?lang=zh_cn&edition=full","pubTime":"2026-03-27 11:56","pubTimestamp":1774583792,"startTime":"0","endTime":"0","summary":"康臣药业今日盘中股价大幅上涨5.15%，引起了市场的关注。消息面上，公司此前公布了2025年度业绩报告。报告显示，集团期内收入同比增长15.17%至34.17亿元，公司权益股东应占溢利同比大幅增长18.41%至10.78亿元。同时，公司拟派发末期股息每股0.4港元。这份强劲的财务表现被认为是推动股价上涨的主要动力。业绩的增长反映了公司业务的稳健发展和盈利能力的提升，增强了投资者对公司未来前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893988","title":"迈威生物、剂泰科技、星环科技递表港交所；特步国际、康臣药业、快手公布2025年年度业绩丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893988","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622893988?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:31","pubTimestamp":1774549863,"startTime":"0","endTime":"0","summary":"NO.1迈威生物、剂泰科技、星环科技递表港交所据港交所3月25日消息，迈威（上海）生物科技股份有限公司-B（以下简称迈威生物，SH688062）、剂泰科技（北京）股份有限公司-P（以下简称剂泰科技）、星环信息科技（上海）股份有限公司（以下简称星环科技，SH688031）已向港交所递交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686067484.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686067484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828714.EUR","LU0327786744.USD","81024","LU0051755006.USD","BK1583","LU0702159699.USD","688062","BK1606","LU0463099449.HKD","LU1023057109.AUD","LU1166156734.SGD","01681","LU1188198961.HKD","LU0140636845.USD","LU0593848301.USD","LU0702159343.USD","BK1575","LU0210526637.USD","LU0244354667.USD","LU2097828631.EUR","LU1794554557.SGD","BK1168","LU0359201612.USD","BK1591","KSTmain","LU0211977185.USD","BK1608","LU1303224171.USD","01024","BK1191","LU0359202008.SGD","LU0588546209.SGD","BK1095","BK1615","LU2097828557.USD","LU2097828805.USD","BK1610","BK0239","BK1590","LU0326950275.SGD","LU1770034418.SGD","BK1512","LU0348766576.USD","LU0348767384.USD","LU0456827905.SGD","BK1502","LU0572944931.SGD","LU1719994722.HKD","LU1251922891.USD","LU1720050803.USD","LU2097828474.EUR","01368","LU0307460666.USD","LU0359201885.HKD","BK0231","XTEPY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622838695","title":"康臣药业(01681)将于6月22日派发末期股息每股0.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622838695","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622838695?lang=zh_cn&edition=full","pubTime":"2026-03-26 12:38","pubTimestamp":1774499930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，该公司将于2026年6月22日派发末期股息每股0.4港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1191","01681","BK4585","BK1606","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622888014","title":"康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元 同比增加18.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888014","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622888014?lang=zh_cn&edition=full","pubTime":"2026-03-26 12:07","pubTimestamp":1774498066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业 发布截至2025年12月31日止年度业绩，该集团取得收入人民币34.17亿元，同比增加15.17%;公司权益股东应占溢利10.78亿元，同比增加18.41%;每股基本盈利1.27元，拟派发末期股息每股0.4港元。肾科药物的销售收入于2025年约为24.0亿元，较上年同比增长约20.3%，持续领跑肾病现代中成药品类。尿毒清颗粒海外拓展也颇有成效，成功登陆印尼市场并登上当地学术舞台。妇儿药物的销售收入于2025年为3.76亿元，较上年同比增长约 4.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元 同比增加18.41%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169697444","title":"康臣药业将于2026年06月22日派发末期股息每股0.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169697444","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169697444?lang=zh_cn&edition=full","pubTime":"2026-03-26 12:05","pubTimestamp":1774497937,"startTime":"0","endTime":"0","summary":"康臣药业(01681)\n根据公司最新公告，董事会宣布派发截至2025年12月31日止年度的末期股息，每股0.4港元。该项股息需于2026年5月26日召开股东大会上获得批准后方可生效。\n公告显示，股份除净日定于2026年6月9日，股东如欲享有是次股息分配，须于2026年6月10日16时30分前递交股份过户文件并完成登记。公司将于2026年6月22日正式派发该笔股息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619162717","title":"每日卖空追踪 | 康臣药业 03月13日卖空量成交4.8万股，卖空比例为1.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619162717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619162717?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:30","pubTimestamp":1773390623,"startTime":"0","endTime":"0","summary":"康臣药业北京时间03月13日，涨0.7%，卖空量成交4.8万股，较上一交易日减少77.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163310a6bd1b21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313163310a6bd1b21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618460909","title":"每日卖空追踪 | 康臣药业 03月11日卖空量成交8.4万股，卖空比例为1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618460909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618460909?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217824,"startTime":"0","endTime":"0","summary":"康臣药业北京时间03月11日，涨0.11%，卖空量成交8.4万股，较上一交易日减少65.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163253a460b5b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163253a460b5b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618656939","title":"康臣药业盘中异动 下午盘大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618656939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618656939?lang=zh_cn&edition=full","pubTime":"2026-03-10 14:20","pubTimestamp":1773123627,"startTime":"0","endTime":"0","summary":"2026年03月10日下午盘14时20分，康臣药业股票出现异动，股价大幅拉升5.01%。截至发稿，该股报17.830港元/股，成交量345.993万股，换手率0.41%，振幅5.06%。康臣药业股票所在的药品行业中，整体涨幅为1.44%。其相关个股中，开拓药业-B、君圣泰医药-B、海西新药涨幅较大，振幅较大的相关个股有开拓药业-B、劲方医药-B、君圣泰医药-B，振幅分别为28.90%、28.10%、17.36%。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031014202897aba5c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031014202897aba5c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618620100","title":"每日卖空追踪 | 康臣药业 03月09日卖空量成交23.2万股，卖空比例为3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620100?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045024,"startTime":"0","endTime":"0","summary":"康臣药业北京时间03月09日，涨4.3%，卖空量成交23.2万股，较上一交易日增加55.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163259a6b1c683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163259a6b1c683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618620432","title":"康臣药业盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620432?lang=zh_cn&edition=full","pubTime":"2026-03-09 14:05","pubTimestamp":1773036340,"startTime":"0","endTime":"0","summary":"2026年03月09日下午盘14时05分，康臣药业股票出现异动，股价大幅上涨5.04%。截至发稿，该股报17.100港元/股，成交量494.817万股，换手率0.59%，振幅6.45%。康臣药业股票所在的药品行业中，整体跌幅为0.72%。其相关个股中，劲方医药-B、海西新药、开拓药业-B涨幅较大，振幅较大的相关个股有宝济药业-B、长风药业、英硅智能，振幅分别为30.67%、27.01%、16.67%。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030914054097aad1c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030914054097aad1c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":0.0261},{"period":"1month","weight":-0.0545},{"period":"3month","weight":-0.084},{"period":"6month","weight":0.076},{"period":"1year","weight":0.7563},{"period":"ytd","weight":0.032}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":0.039},{"period":"3month","weight":-0.0275},{"period":"6month","weight":0.0062},{"period":"1year","weight":0.1596},{"period":"ytd","weight":0.0182}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家主要从事药品生产及销售业务的公司。该公司通过两个部门开展业务。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。玉林制药分部主要从事生产及销售传统中成药业务。该公司的产品主要包括肾科药物、妇儿药物、对比剂、骨科药物、皮肤科药物、肝胆药物和其他。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.045412},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016845},{"month":3,"riseRate":0.461538,"avgChangeRate":0.017217},{"month":4,"riseRate":0.692308,"avgChangeRate":0.059396},{"month":5,"riseRate":0.538462,"avgChangeRate":0.032336},{"month":6,"riseRate":0.416667,"avgChangeRate":0.002936},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010529},{"month":8,"riseRate":0.583333,"avgChangeRate":0.012771},{"month":9,"riseRate":0.583333,"avgChangeRate":0.028269},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025864},{"month":11,"riseRate":0.5,"avgChangeRate":0.008603},{"month":12,"riseRate":0.583333,"avgChangeRate":0.021467}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}